Sharemaestro Newsreel

CVS Health (NYSE:CVS) Stock Rating Lowered by Wall Street Zen

Wall Street Zen has downgraded CVS Health (NYSE:CVS) from "buy" to "hold," despite other analysts raising price targets and a generally positive outlook from a broader analyst pool. CVS Health reported strong quarterly results, exceeding both earnings and revenue expectations, but faces ongoing regulatory …

How Expanded Coverage for Guardant’s Shield Test Will Impact UnitedHealth Group (UNH) Investors

UnitedHealth Group's decision to cover Guardant Health's Shield blood test for colorectal cancer screening for roughly 40 million members over 45 aligns with its focus on preventive care. While this move supports UnitedHealth's long-term investment narrative through innovation and efficiency, it's overshadowed by ongoing …

MOH6320596 Bond Profile — Key Metrics

This article provides key financial metrics and an overview of the MOH6320596 bond issued by Molina Healthcare, Inc. The bond has a coupon rate of 6.50%, was issued on November 20, 2025, and matures on February 15, 2031, with an outstanding amount of $850.00 …

MOH5003223 Bond Risk Profile

This page provides a risk profile for the "Molina Healthcare, Inc. 4.375% 15-JUN-2028" bond, identified as MOH5003223. It offers an in-depth bond breakdown including coupon, redemption, and various risks, with a focus on credit risk assessment. The page highlights key metrics for security levels, …

Alignment healthcare CEO John Kao sells $5.9m in ALHC shares

John E. Kao, CEO of Alignment Healthcare (NASDAQ:ALHC), sold 298,000 shares worth approximately $5.92 million on July 10, 2026, through a pre-arranged trading plan. This sale occurred while the stock declined 15% over the past week but remains up 52% over the last year. …

A Look at Alignment Healthcare Inc (ALHC) After 4.0% Gain -- GF Value $19.34 vs Price $21.21

Alignment Healthcare Inc (ALHC) shares gained 4.0% to $21.21, but are considered 9.7% overvalued according to GuruFocus' GF Value of $19.34. The stock has a GF Score of 78/100, indicating good long-term potential, though profitability and momentum scores are low. Insider selling totaling $15.8 …

CVS stalls just under its 52-week high while Healthcare Plans breadth does the heavy lifting

CVS Health closed at $104.2, only 1.9% below its 52-week peak, but the latest weekly move lacked volume confirmation and relative strength has cooled over four weeks.

UnitedHealth’s 95% range position has plan-peer breadth behind it, while volume stays light

UNH finished the week little changed at $424.6, just 2.2% below its 52-week high, with an active Trend Signal and strong Healthcare Plans breadth offset by below-average participation.

Centene Corp (CNC) recovery stretches to 81.9% over 12 weeks

The managed-care stock is showing an active weekly trend, though trading volume remains below its 13-week average.

Progyny (PGNY): Buy, Sell, or Hold Post Q1 Earnings?

Humana Inc (HUM) rebound builds in weekly context

The healthcare-plan stock’s latest weekly move adds to a strong three-month recovery, though participation remains lighter than its recent average.

Centene’s 81.9% quarter leans on Healthcare Plans breadth, not heavy volume

Centene closed just 2.1% below its 52-week high, with the managed-care group providing strong confirmation even as the latest advance came on only 0.7x recent volume.

UnitedHealth Group Incorporated (UNH) extends rebound with 55.2% twelve-week climb

The healthcare plans stock remains in an active trend, though volume and strength readings leave the confirmation less than uniform.

Humana Inc (HUM) puts 115.8% 12-week rebound in focus

The managed-care stock is recovering quickly, though confirmation outside price remains mixed.

Centene Corp (CNC) weekly chart reflects an 87.2% 12-week surge

The managed-care insurer’s rebound has active trend confirmation, though participation is running below its recent volume norm.

Humana Inc (HUM) weekly advance carries managed-care rebound

The insurer’s 52-week weekly chart frames the move as a continuing recovery in healthcare plans, with confirmation still selective.

Humana Inc (HUM) weekly pullback interrupts a sharp rebound

The healthcare-plan stock is still carrying strong medium-term gains, but the latest week shows pressure returning to the tape.

Centene Corp (CNC) weekly pullback tests a still-active healthcare-plan trend

The managed-care stock fell on the week, but the broader 52-week setup still shows substantial medium-term gains and near-average turnover.

Centene Corp (CNC) weekly slide tests still-active trend

Longer-horizon gains still complicate the latest setback in the healthcare-plan stock.

Elevance’s 3.9% drop jars with strong managed-care breadth as volume stays light

Elevance Health remains above its weekly Trend Line, but the latest pullback left it trailing a strongly supported Healthcare Plans group and still below Sharemaestro Fair Value.

Humana Inc (HUM) slips after a powerful 12-week rebound

The healthcare-plan stock remains in an active weekly trend, but softer relative strength and a down week make the setup mixed.

Centene Corp (CNC) weekly pullback interrupts managed-care rebound

The latest weekly move leaves the setup mixed, with a short-term setback set against a still-large 12-week advance.

Centene Corp (CNC) pushes higher as four-week gain reaches 11.9%

The managed-care insurer’s active trend keeps the rebound in focus, though relative strength is still short of a clear leadership reading.

Humana Inc (HUM) posts 124.4% 12-week rebound in healthcare plans

The weekly setup remains active, but lighter turnover keeps the confirmation short of one-way strength.

Centene Corp (CNC) puts 89.5% 12-week rebound in focus

The healthcare-plan stock closed at $65.19, with weekly market data showing gains across the one-, four- and twelve-week periods.

Humana Inc (HUM) rebounds as weekly participation lags

The healthcare-plan stock is recovering strongly, but volume remains below its recent weekly norm.

CVS reaches the top of its yearly range as managed-care breadth outpaces broader Healthcare

CVS Health finished the week at $102.00, only 0.8% below its 52-week high, with an active Trend Signal and stronger industry backing than the wider Healthcare sector.

Humana Inc (HUM) regains momentum with 24.3% four-week climb

The healthcare-plan stock remains in an active weekly trend, but lighter turnover keeps the confirmation less than decisive.

UnitedHealth’s 48% quarter approaches the high, but healthcare-plan peers are setting a hotter pace

UNH added 2.3% for the week and is only 1.8% below its 52-week high, with the Trend Signal active for a fourth week. The caution is participation: volume sat at 0.9x the 13-week average while the Healthcare Plans group rose far faster.

Centene Corp (CNC) holds active weekly trend as volume confirmation stays uneven

A strong recovery in the managed-care insurer remains intact, but the supporting signals are not uniformly strong.

Humana is back at its 52-week high after a 124% quarter, but volume has not kept pace

Humana closed at $379.20, within 0.1% of its 52-week high, as Healthcare Plans remain one of the strongest groups in US Healthcare. The advance is powerful, but the latest week came on only 0.7x normal volume.

Humana Inc (HUM) 12-week rebound reaches 124.4% in weekly context

The healthcare-plan stock is rallying, but lighter participation keeps the setup from looking one-sided.

Centene sits 2% below its 52-week high, with managed-care strength stronger than volume confirmation

Centene added 4.6% for the week and remains in an active seven-week Trend Signal, but participation is only average as the stock trades above both Fair Value and its weekly Trend Line.

What Progyny (PGNY)'s Governance Shift And $200 Million Buyback Mean For Shareholders

Progyny Buyback Raises Questions On Capital Returns And Growth Plans

Progyny (PGNY) Is Up 7.0% After Analyst Upgrade Backed By Six Earnings Beats And 2026 Outlook